PEPTIDE DATABASE

Tirzepatide

Mounjaro; Zepbound; LY3298176

A peptide-based dual agonist targeting GIP and GLP-1 receptors, developed for metabolic disease and weight-management indications.

Dual GIP / GLP-1 receptor agonist Established clinical compound Approved prescription drug for specific indications in multiple jurisdictions

COMPOUND DATA

Molecular Information

Classification Dual GIP / GLP-1 receptor agonist

Molecular Weight Not available

Molecular Formula Not available

Research Status Established clinical compound

BIOLOGICAL ATLAS

Systems Associated With Tirzepatide

Brain & CNS

Approved / Established

Established pharmacological pathway

Dual GIP and GLP-1 receptor agonist with extensive human metabolic and glucose-regulatory research.

Cardiovascular

Approved / Established

Established pharmacological pathway

Dual GIP and GLP-1 receptor agonist with extensive human metabolic and glucose-regulatory research.

Gastrointestinal

Approved / Established

Established pharmacological pathway

Dual GIP and GLP-1 receptor agonist with extensive human metabolic and glucose-regulatory research.

Liver

Approved / Established

Established pharmacological pathway

Dual GIP and GLP-1 receptor agonist with extensive human metabolic and glucose-regulatory research.

Pancreas & Glucose

Approved / Established

Established pharmacological pathway

Dual GIP and GLP-1 receptor agonist with extensive human metabolic and glucose-regulatory research.

Metabolic

Approved / Established

Established pharmacological pathway

Dual GIP and GLP-1 receptor agonist with extensive human metabolic and glucose-regulatory research.

Adipose Tissue

Approved / Established

Established pharmacological pathway

Dual GIP and GLP-1 receptor agonist with extensive human metabolic and glucose-regulatory research.

Endocrine & Hormonal

Approved / Established

Established pharmacological pathway

Dual GIP and GLP-1 receptor agonist with extensive human metabolic and glucose-regulatory research.

STATUS

Regulatory Information

Approved prescription drug for specific indications in multiple jurisdictions

Regulatory status can vary by jurisdiction and may change over time.

HAXBIO COMMUNITY

Tirzepatide Discussions & News

HaxBio provides information for educational and research purposes. Information on this page should not be interpreted as medical advice.